IP Library Granted Patent US 11,103,574
Granted Patent B2
US 11,103,574 · App. 16/342,070 · Granted Aug 31, 2021

Infectious disease vaccine using non-infectious paramyxovirus particle

Inventors: Tetsuro Matano (Tokyo, JP); Makoto Inoue (Tokyo, JP); Hiroto Hara (Tokyo, JP); Tsugumine Shu (Tokyo, JP)
Assignees: Japan, as represented by the Director-General of National Institute of Infectious Disease; ID Pharma Co., Ltd.
A61K39/21C12N7/00C12N2740/10022C12N2740/10034C12N2760/18823C12N2760/18843
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,103,574
App. No.
16/342,070
Granted
Aug 31, 2021
Kind
B2
Abstract

In this invention, a non-infectious particle has been produced, comprising a pathogen antigen protein caused to be expressed on the surface of a virus particle having at least one species of paramyxovirus envelope protein missing from the particle. This particle has been found to hold within the particle a large amount of antigen protein compared to an infectious particle, and to be capable of eliciting a host immune response with extremely high efficiency. The non-infectious particle according to the present invention is useful as a vaccine against a pathogenic virus, or the like.

Claims (13)

1. A F gene-deleted Sendai virus non-infectious particle, which lacks F protein of the Sendai virus on the surface of the virus particle, and holds an antigen protein of a heterologous pathogen on the surface of the virus particle, wherein the antigen protein of the heterologous pathogen is a fusion protein containing an antigen fragment of the pathogen at the outer side of the virus particle and a cytoplasmic region fragment of the F protein at the inner side of the virus particle.

2. The non-infectious particle of claim 1 , wherein the antigen protein of the heterologous pathogen comprises all or part of an envelope protein of a retrovirus.

3. The non-infectious particle of claim 1 , wherein the antigen protein of the heterologous pathogen comprises all or part of an envelope protein of HTLV-1 or HIV-1.

4. A composition comprising the non-infectious particle of claim 1 .

5. A vaccine formulation comprising the non-infectious particle of claim 1 .

6. The vaccine formulation of claim 5 , which is for use in booster inoculation.

7. The vaccine formulation of claim 5 , which is used in booster inoculation, wherein the pathogen is different from a pathogen from which an antigen for primary inoculation is derived.

8. A method for producing the non-infectious particle of claim 1 , which comprises introducing into a cell a Sendai vector from which at least F protein gene has been deleted and which carries an antigen protein gene of a heterologous pathogen, and collecting a generated paramyxovirus non-infectious particle.

9. The non-infectious particle of claim 1 , wherein the antigen fragment of the pathogen is all or part of an ectodomain of an envelope protein of a pathogenic virus.

10. The non-infectious particle of claim 9 , wherein the pathogenic virus is a retrovirus.

11. The non-infectious particle of claim 9 , wherein the pathogenic virus is a T cell infectious retrovirus.

12. The non-infectious particle of claim 11 , wherein the T cell infectious virus is HTLV-1.

13. The non-infectious particle of claim 11 , wherein the T cell infectious virus is HIV-1.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 3, 2026
From: ID PHARMA CO., LTD.
To: JAPAN INSTITUTE FOR HEALTH SECURITY
Reel/Frame 075339/0544 →
CHANGE OF NAME Recorded Oct 30, 2025
From: JAPAN AS REPRESENTED BY THE DIRECTOR-GENERAL OF NATIONAL INSTITUTE OF INFECTIOUS DISEASES
To: JAPAN INSTITUTE FOR HEALTH SECURITY
Reel/Frame 073278/0140 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2019
From: MATANO, TETSURO
To: JAPAN, AS REPRESENTED BY THE DIRECTOR-GENERAL OF NATIONAL INSTITUTE OF INFECTIOUS DISEASES
Reel/Frame 050177/0418 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2019
From: INOUE, MAKOTO; HARA, HIROTO; SHU, TSUGUMINE
To: ID PHARMA CO., LTD.
Reel/Frame 050177/0637 →
Priority Claims (1)
JP JP2016-224475 · Nov 17, 2016 · national
Continuity (1)
Related Publication 20200155669A1 · May 21, 2020